Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb-Mar;26(3-4):95-105.
doi: 10.1080/14622416.2025.2490467. Epub 2025 Apr 16.

Association of SOD1 rs36232792 with opioid use disorder and a novel PCR-RFLP method for SOD2 rs5746136

Affiliations

Association of SOD1 rs36232792 with opioid use disorder and a novel PCR-RFLP method for SOD2 rs5746136

Seval Küçükparmaksız et al. Pharmacogenomics. 2025 Feb-Mar.

Abstract

Aim: The aim of this study is to find out the effect of SOD1 rs36232792 and SOD2 rs5746136 on the risk of opioid use disorder (OUD).

Methods: Individuals with OUD (n = 101) and controls (n = 104) were included. SOD1 rs36232792 was genotyped by PCR. A novel PCR-RFLP method for SOD2 rs5746136 was optimized.

Results: A significant difference was observed between individuals with OUD and controls in view of the frequency of 'Ins/Del+Del/Del' genotypes of the SOD1 rs36232792 (p = 0.049), but not for SOD2 rs5746136 (p = 0.254). The intensity of anxiety and depressive symptoms was significantly higher in individuals with OUD compared to controls (p = 0.001).

Conclusion: The SOD1 rs36232792 polymorphism could contribute to the risk of OUD in a Turkish population. A novel PCR-RFLP method for SOD2 rs5746136 confirmed by sequencing can be used in a research laboratory without advanced equipment.

Keywords: Opioid use disorder; SOD1; SOD2; antioxidant enzymes; interindividual variability.

PubMed Disclaimer

Conflict of interest statement

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.

Similar articles

References

    1. Eitan S, Emery MA, Bates MLS, et al. Opioid addiction: who are your real friends? Neurosci Biobehav Rev. 2017;83:697–712. doi: 10.1016/j.neubiorev.2017.05.017 - DOI - PubMed
    1. Evren EC. Bağımlılığın Moleküler ve Hücresel Temeli. Klinik Psikofarmakoloji Bülteni. 1998;8(1):47–50.
    1. Azadfard M, Huecker MR, Leaming JM. Opioid addiction. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing ; 2023. https://www.ncbi.nlm.nih.gov/books/NBK448203/ - PubMed
    1. Kreek MJ, Nielsen DA, LaForge KS. Genes associated with addiction: alcoholism, opiate, and cocaine addiction. Neuromolecular Med. 2004;5(1):85–108. doi: 10.1385/NMM:5:1:085 - DOI - PubMed
    1. Wang SC, Chen YC, Lee CH, et al. Opioid addiction, genetic susceptibility, and medical treatments: a review. Int J Mol Sci. 2019;20(17):4294. doi: 10.3390/ijms20174294 - DOI - PMC - PubMed

LinkOut - more resources